Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

0.8020
+0.04475.90%
Post-market: 0.82000.0180+2.24%19:38 EDT
Volume:1.42M
Turnover:1.13M
Market Cap:64.24M
PE:2.12
High:0.8250
Open:0.7700
Low:0.7602
Close:0.7573
Loading ...
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 04, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals